Tech
Driving digital transformation for medical tech companies
Published
2 years agoon
By
Drew Simpson
Medical technology and pharmaceutical companies are transitioning beyond biopharmaceuticals, medical devices, and equipment to provide comprehensive patient care. The key is to support proactive, predictive, and personalized care delivery and management that is sustainable. This involves enabling better outcomes, improving patient and clinician experience in care pathways, reducing health-care costs, removing inefficiencies in workflows, and maximizing the convergence of capabilities.
In a bid for relevance and differentiation, many medical technology and pharma companies have embraced digitization. Digitization is now seen as an enabler of this transition as health-care companies strive to enhance value for their customers and partners.
With the availability of digital tools and technologies, the industry aims to accelerate the use of health-care data for process improvement, product development, and value proposition enhancement while looking at new monetization models.
Succeeding with digital transformation
Medical technology companies have always had to choose where to invest their research-and-development resources: on prioritizing developing their core competencies and solutions or on digital infrastructure and analytical capabilities. Although both are essential, not all firms have the funds to do both or the skill sets to develop capabilities in data management or analysis algorithms, or the partner ecosystem to leverage, collaborate, co-create, and share risk. Furthermore, these firms may not have experience in setting up governance and compliance structures to use clinical data in compliance with regulations.
Specific internal capabilities, as well as planning and resources are required to develop and maintain a digital ecosystem to realize the multiple benefits of data, analytics, and collaboration with appropriate partners. Platforms offer a cloud-based ecosystem for secure access and data sharing among multiple stakeholders, enabled by digital tools and applications while providing an avenue for like-minded firms to collaborate.
In this way, platform as a service (PaaS) allows users to leverage a subscription-based data and cloud computing service without the complexity of building and maintaining the infrastructure. It allows users to access, develop, and run applications, and unify digital transformation using a single platform, reducing the use of resources needed to drive transformation.
“Data is in silos, and to optimize clinical pathways, all stakeholders need to work together by co-creating and co-opeting,” says Max Milz, senior partner and senior vice president at Siemens Advanta Consulting. “In other words, data needs to be accessed, processed, stored, analyzed, and shared in a secure and compliant manner for it to be useful to different stakeholders. PaaS is one of the enablers for driving this integration. Medical technology companies can accelerate their digital transformation efforts by leveraging first-mile connectivity to a hospital ecosystem and last-mile access to data offered by the teamplay digital health platform.”
Medical technology needs a specific platform
Most health-care data management use cases are industry-specific with requirements to access imaging, pathology, and clinical data. Stakeholders considering a platform would benefit from collaborating with one that has domain specificity and is incubated and managed by another experienced medical technology organization.
A platform specific to medical technology offers vertical domain expertise from a market access and connectivity perspective, access to relevant data, specific applications for that sector, and experience of the security and regulatory compliance requirements, allowing partners to focus on the development of their core solutions and value propositions. Using a medical technology PaaS offers medical equipment and device companies the flexibility to adapt continuously to evolving market needs, optimizing investment in time and resources while being guided by a valued partner with experience of developing a platform fit for purpose.
In a competitive market, medical technology companies must focus on accelerated product development while partnering with the best PaaS provider to help realize their overall digital transformation goals.
“The majority of medical technology companies have a strong product presence,” explains Thomas Friese, senior vice president for digital platforms at Siemens Healthineers. “However, what they also need is to transform to a sustainable service model.”
And there’s no need to go it alone. “Co-opetition is gathering prominence in medical technology and pharma, and all stakeholders stand to only benefit from integration. PaaS will become very relevant in this context, thus positioning teamplay digital health platform uniquely, with its domain-specific expertise and digital transformation capabilities,” Friese says.
A proven and compliant PaaS platform: teamplay
A company with extensive experience in imaging and diagnostics can build a platform that brings together a strong diagnostic and therapeutic core and specialized digital offerings, and systematically expand it across multiple functionalities.
Several use cases can be used as templates for technology advancement, enabling partners to achieve their objectives. teamplay acts as a technology accelerator for medical technology companies, providing first-mile connectivity and last-mile access.
As a medical technology-specific platform provider, Siemens Healthineers offers vertical domain expertise and industry expertise, differentiating it from horizontal platform capabilities offered by leading IT companies. The subscription model also allows users to spread the investment over time and generate higher returns by giving partners a head start. Overall, Siemens Healthineers has a clear vision of where it fits with partners by increasing fidelity and ease of use while decreasing time and effort for its partners.
Partnering offers advantages for digital transformation
The advantages of partnering in creating a PaaS are evident: it is a more strategic and long-term option with the opportunity to collaborate, co-create, and share risk. Compared with building a platform, partnering provides scalability by optimizing time, resources, and investment. While building a platform with a public cloud services provider, medical technology companies are still required to network with hospitals for data access and arrange integration with devices and the health-care IT ecosystem.
Partnering with a medical technology PaaS, however, offers scalability in terms of access and connectivity and the ability for the platform to evolve by onboarding new products, applications, and vendors.
Medical technology companies must choose a partner whose vision, breadth, and service align with overall digital transformation efforts. Partnering with Siemens Healthineers enables access to a tried and tested platform that is compliant, secure, and acts as a technology accelerator. It further offers the potential to focus on core competencies while collaborating to explore new and adjacent opportunities.
The teamplay digital health platform connects and integrates data from various sources across departments and institutions on a vendor-, system- and device-neutral platform. It offers scalable deployment models with hybrid computing, combining cloud and on-edge deployment to serve specific use cases. Access is also open to innovations and solutions in AI and digital health from Siemens Healthineers and its curated partner network with opportunities for collaboration with peers and partners that enables risk-sharing models. It allows the deployment and operation of applications and algorithms globally by leveraging the secure platform infrastructure.
Most important, with Siemens Healthineers, medical technology companies have the opportunity to partner with a platform that is continuously being developed and delivers clinical credibility and business relevance.
Learn more about PaaS technology in health care.
This content was produced by Insights, the custom content arm of MIT Technology Review. It was not written by MIT Technology Review’s editorial staff.
You may like
-
Top 10 IT Staff Augmentation Companies in 2023
-
5 Benefits Engineers Can Bring to a Tech Hiring Team
-
Alternatives to Layoffs in Tech: Maintaining a Stable Workforce
-
Tech that aims to read your mind and probe your memories is already here
-
Chinese tech giant Baidu releases its answer to ChatGPT
-
AI Powers the Next Generation of Personalized Digital Marketing
Tech
Newly revealed coronavirus data has reignited a debate over the virus’s origins
Published
58 mins agoon
03/24/2023By
Drew Simpson
Data collected in 2020—and kept from public view since then—potentially adds weight to the animal theory. It highlights a potential suspect: the raccoon dog. But exactly how much weight it adds depends on who you ask. New analyses of the data have only reignited the debate, and stirred up some serious drama.
The current ruckus starts with a study shared by Chinese scientists back in February 2022. In a preprint (a scientific paper that has not yet been peer-reviewed or published in a journal), George Gao of the Chinese Center for Disease Control and Prevention (CCDC) and his colleagues described how they collected and analyzed 1,380 samples from the Huanan Seafood Market.
These samples were collected between January and March 2020, just after the market was closed. At the time, the team wrote that they only found coronavirus in samples alongside genetic material from people.
There were a lot of animals on sale at this market, which sold more than just seafood. The Gao paper features a long list, including chickens, ducks, geese, pheasants, doves, deer, badgers, rabbits, bamboo rats, porcupines, hedgehogs, crocodiles, snakes, and salamanders. And that list is not exhaustive—there are reports of other animals being traded there, including raccoon dogs. We’ll come back to them later.
But Gao and his colleagues reported that they didn’t find the coronavirus in any of the 18 species of animal they looked at. They suggested that it was humans who most likely brought the virus to the market, which ended up being the first known epicenter of the outbreak.
Fast-forward to March 2023. On March 4, Florence Débarre, an evolutionary biologist at Sorbonne University in Paris, spotted some data that had been uploaded to GISAID, a website that allows researchers to share genetic data to help them study and track viruses that cause infectious diseases. The data appeared to have been uploaded in June 2022. It seemed to have been collected by Gao and his colleagues for their February 2022 study, although it had not been included in the actual paper.
Tech
Fostering innovation through a culture of curiosity
Published
6 hours agoon
03/24/2023By
Drew Simpson
And so I think a big part of it as a company, by setting these ambitious goals, it forces us to say if we want to be number one, if we want to be top tier in these areas, if we want to continue to generate results, how do we get there using technology? And so that really forces us to throw away our assumptions because you can’t follow somebody, if you want to be number one you can’t follow someone to become number one. And so we understand that the path to get there, it’s through, of course, technology and the software and the enablement and the investment, but it really is by becoming goal-oriented. And if we look at these examples of how do we create the infrastructure on the technology side to support these ambitious goals, we ourselves have to be ambitious in turn because if we bring a solution that’s also a me too, that’s a copycat, that doesn’t have differentiation, that’s not going to propel us, for example, to be a top 10 supply chain. It just doesn’t pass muster.
So I think at the top level, it starts with the business ambition. And then from there we can organize ourselves at the intersection of the business ambition and the technology trends to have those very rich discussions and being the glue of how do we put together so many moving pieces because we’re constantly scanning the technology landscape for new advancing and emerging technologies that can come in and be a part of achieving that mission. And so that’s how we set it up on the process side. As an example, I think one of the things, and it’s also innovation, but it doesn’t get talked about as much, but for the community out there, I think it’s going to be very relevant is, how do we stay on top of the data sovereignty questions and data localization? There’s a lot of work that needs to go into rethinking what your cloud, private, public, edge, on-premise look like going forward so that we can remain cutting edge and competitive in each of our markets while meeting the increasing guidance that we’re getting from countries and regulatory agencies about data localization and data sovereignty.
And so in our case, as a global company that’s listed in Hong Kong and we operate all around the world, we’ve had to really think deeply about the architecture of our solutions and apply innovation in how we can architect for a longer term growth, but in a world that’s increasingly uncertain. So I think there’s a lot of drivers in some sense, which is our corporate aspirations, our operating environment, which has continued to have a lot of uncertainty, and that really forces us to take a very sharp lens on what cutting edge looks like. And it’s not always the bright and shiny technology. Cutting edge could mean going to the executive committee and saying, Hey, we’re going to face a challenge about compliance. Here’s the innovation we’re bringing about architecture so that we can handle not just the next country or regulatory regime that we have to comply with, but the next 10, the next 50.
Laurel: Well, and to follow up with a bit more of a specific example, how does R&D help improve manufacturing in the software supply chain as well as emerging technologies like artificial intelligence and the industrial metaverse?
Art: Oh, I love this one because this is the perfect example of there’s a lot happening in the technology industry and there’s so much back to the earlier point of applied curiosity and how we can try this. So specifically around artificial intelligence and industrial metaverse, I think those go really well together with what are Lenovo’s natural strengths. Our heritage is as a leading global manufacturer, and now we’re looking to also transition to services-led, but applying AI and technologies like the metaverse to our factories. I think it’s almost easier to talk about the inverse, Laurel, which is if we… Because, and I remember very clearly we’ve mapped this out, there’s no area within the supply chain and manufacturing that is not touched by these areas. If I think about an example, actually, it’s very timely that we’re having this discussion. Lenovo was recognized just a few weeks ago at the World Economic Forum as part of the global lighthouse network on leading manufacturing.
And that’s based very much on applying around AI and metaverse technologies and embedding them into every aspect of what we do about our own supply chain and manufacturing network. And so if I pick a couple of examples on the quality side within the factory, we’ve implemented a combination of digital twin technology around how we can design to cost, design to quality in ways that are much faster than before, where we can prototype in the digital world where it’s faster and lower cost and correcting errors is more upfront and timely. So we are able to much more quickly iterate on our products. We’re able to have better quality. We’ve taken advanced computer vision so that we’re able to identify quality defects earlier on. We’re able to implement technologies around the industrial metaverse so that we can train our factory workers more effectively and better using aspects of AR and VR.
And we’re also able to, one of the really important parts of running an effective manufacturing operation is actually production planning, because there’s so many thousands of parts that are coming in, and I think everyone who’s listening knows how much uncertainty and volatility there have been in supply chains. So how do you take such a multi-thousand dimensional planning problem and optimize that? Those are things where we apply smart production planning models to keep our factories fully running so that we can meet our customer delivery dates. So I don’t want to drone on, but I think literally the answer was: there is no place, if you think about logistics, planning, production, scheduling, shipping, where we didn’t find AI and metaverse use cases that were able to significantly enhance the way we run our operations. And again, we’re doing this internally and that’s why we’re very proud that the World Economic Forum recognized us as a global lighthouse network manufacturing member.
Laurel: It’s certainly important, especially when we’re bringing together computing and IT environments in this increasing complexity. So as businesses continue to transform and accelerate their transformations, how do you build resiliency throughout Lenovo? Because that is certainly another foundational characteristic that is so necessary.
Tech
The Download: covid’s origin drama, and TikTok’s uncertain future
Published
11 hours agoon
03/24/2023By
Drew Simpson
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
Newly-revealed coronavirus data has reignited a debate over the virus’s origins
This week, we’ve seen the resurgence of a debate that has been swirling since the start of the pandemic—where did the virus that causes covid-19 come from?
For the most part, scientists have maintained that the virus probably jumped from an animal to a human at the Huanan Seafood Market in Wuhan at some point in late 2019. But some claim that the virus leaped from humans to animals, rather than the other way around. And many continue to claim that the virus somehow leaked from a nearby laboratory that was studying coronaviruses in bats.
Data collected in 2020—and kept from public view since then—potentially adds weight to the animal theory. It highlights a potential suspect: the raccoon dog. But exactly how much weight it adds depends on who you ask. Read the full story.
—Jessica Hamzelou
This story is from The Checkup, Jessica’s weekly biotech newsletter. Sign up to receive it in your inbox every Thursday.
Read more of MIT Technology Review’s covid reporting:
+ Our senior biotech editor Antonio Regalado investigated the origins of the coronavirus behind covid-19 in his five-part podcast series Curious Coincidence.
+ Meet the scientist at the center of the covid lab leak controversy. Shi Zhengli has spent years at the Wuhan Institute of Virology researching coronaviruses that live in bats. Her work has come under fire as the world tries to understand where covid-19 came from. Read the full story.
+ This scientist now believes covid started in Wuhan’s wet market. Here’s why. Michael Worobey of the University of Arizona, believes that a spillover of the virus from animals at the Huanan Seafood market was almost certainly behind the origin of the pandemic. Read the full story.
The must-reads
I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.
1 TikTok’s future in the US is hanging in the balance
Banning it is a colossal challenge, and officials still lack the legal authority to do so. (WP $)
+ TikTok CEO Shou Zi Chew was grilled by a congressional committee. (FT $)
+ He told lawmakers the company would earn their trust. (WSJ $)
+ Meanwhile, TikTok paid for influencers to travel to DC to lobby its cause. (Wired $)
2 A crypto fugitive has been arrested in Montenegro
Do Kwon has been on the run since TerraUSD stablecoin collapsed last year. (WSJ $)
+ Want to mine Bitcoin? Get yourself to Texas. (Reuters)
+ What’s next for crypto. (MIT Technology Review)
3 Twitter’s getting rid of its legacy blue checks
On the entirely serious date of April 1. (The Verge)+ The platform’s still an unattractive prospect for advertisers. (Vox)
4 Chatbots are having tough conversations for us
ChatGPT is adept at writing scripts for sensitive talks with kids and colleagues. (NYT $)
+ OpenAI has given ChatGPT access to the web’s live data. (The Verge)
+ How Character.AI became a billion-dollar unicorn. (WSJ $)
+ The inside story of how ChatGPT was built from the people who made it. (MIT Technology Review)
5 Jack Dorsey’s Block has been accused of fraudulent transactions
The payments company denied it, and claims it inflated its users numbers, too.(FT $)
+ Dorsey doesn’t have a track record of caring about this kind of thing. (The Information $)
6 Homeowners associations are secretly installing surveillance systems
The system tracks license plates and follows residents’ movements. (The Intercept)
7 Inside the tricky ethics of using DNA to solve crimes
A new database could help to protect users’ privacy. (Wired $)|
+ The citizen scientist who finds killers from her couch. (MIT Technology Review)
8 There’s plenty of reasons to be optimistic about the climate
Healthier, more sustainable diets are a good place to start. (Scientific American)
+ Taking stock of our climate past, present, and future. (MIT Technology Review)
9 TikTok keeps hectoring us
It seems we just can’t get enough of being aggressively told what to do. (Vox)
10 Don’t get scammed by a deepfake
CallerID can’t be trusted to protect you from rogue AI calls. (Gizmodo)
Quote of the day
“Wait, I need content.”
—TikTok fashion creator Kristine Thompson refuses to miss a content opportunity during a trip to the US Capitol to lobby against a potential TikTok ban, she tells the New York Times.
The big story
This sci-fi blockchain game could help create a metaverse that no one owns
November 2022
Dark Forest is a vast universe, and most of it is shrouded in darkness. Your mission, should you choose to accept it, is to venture into the unknown, avoid being destroyed by opposing players who may be lurking in the dark, and build an empire of the planets you discover and can make your own.
But while the video game seemingly looks and plays much like other online strategy games, it doesn’t rely on the servers running other popular online strategy games. And it may point to something even more profound: the possibility of a metaverse that isn’t owned by a big tech company. Read the full story.
—Mike Orcutt
We can still have nice things
A place for comfort, fun and distraction in these weird times. (Got any ideas? Drop me a line or tweet ’em at me.)
+ If underwater terrors are your thing, Joe Romiero takes some seriously impressive shark pictures and videos.
+ Try as it might, Ted Lasso’s British dialog falls wide of the mark.
+ Let’s have a good old snoop around some celebrities’ bedrooms.
+ Why we can’t get enough of those fancy candles.
+ Interviewing animals with a tiny microphone, it doesn’t get much better than that.